Literature DB >> 13472637

Clinical-cytological correlations of mammary carcinoma based upon sex-chromatin counts; a preliminary study.

V M KIMEL.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/pathology; CHROMOSOMES; SEX CHARACTERISTICS

Mesh：

Substances：

Year:  1957        PMID： 13472637     DOI： 10.1002/1097-0142(195709/10)10:5<922::aid-cncr2820100509>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  12 in total

1.  [On the significance and conclusiveness of nuclear sex diagnosis].

Authors:  C OVERZIER
Journal:  Klin Wochenschr       Date:  1961-06-01

2.  MALNUTRITION and peripheral nerve disorders.

Authors: 
Journal:  Br Med J       Date:  1958-05-31

3.  [Barr bodies and chromatin structures in benign malignant breast tumors].

Authors:  H B von Seebach; H A Müller
Journal:  Z Krebsforsch       Date:  1966

4.  Cancer and sex chromosomes.

Authors: 
Journal:  Br Med J       Date:  1968-07-06

5.  [Supplemental hormone treatment of operable breast neoplasms].

Authors:  P N Ehlers
Journal:  Langenbecks Arch Chir       Date:  1970-12

6.  [Barr bodies in thyroid gland carcinoma].

Authors:  S Kamba; A Matsunaga; H Asayama
Journal:  Jpn J Surg       Date:  1971-09

7.  [On the problem of nuclear sex determination in human carcinoma].

Authors:  W Werner; A Vogel; R Uhlig
Journal:  Langenbecks Arch Chir       Date:  1966

8.  [Sex chromatin bodies in breast tumors of various degrees of differentiation].

Authors:  U Fierz; C Hedinger
Journal:  Klin Wochenschr       Date:  1966-04-01

9.  The sex chromatin and heterochromatic bodies in human diploid and polyploid nuclei.

Authors:  H P KLINGER; H G SCHWARZACHER
Journal:  J Biophys Biochem Cytol       Date:  1960-10

10.  Steroid hormone receptors and sex chromatin frequency in breast cancer.

Authors:  M Smethurst; N P Bishun; D Fernandez; J Allen; J I Burn; J Alaghband-Zadeh; D C Williams
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.